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Abstract
Background Claudin proteins are a component of tight junctions found in cell-cell adhesion complexes. A central feature of
necrotizing enterocolitis (NEC) is intestinal permeability, with changes to claudin proteins potentially contributing to intestinal
instability, inflammation, and the progression of NEC. A current area of interest is the development of a novel, noninvasive
biomarker for the detection of NEC in neonates at risk of developing this disease, in order to reduce morbidity and mortality
through earlier intervention.
Aims This review aims to explore the relevance of claudin proteins in the pathophysiology of NEC and their potential usefulness
as a biomarker.
Methods This review was conducted using the search terms “claudin” + “necrotizing enterocolitis”, with 27 papers selected for
review.
Results Claudin proteins appear to have a role in the stability of the gut epithelium through the regulation of intestinal perme-
ability, maturity, and inflammation. Formula feeding has been shown to promote inflammation and result in changes to claudin
proteins, while breastfeeding and certain nutritional supplements lead to reduced inflammation and improved intestinal stability
as demonstrated through changes to claudin protein expression. Preliminary studies in human neonates suggest that urinary
claudin measurements may be used to predict the development of NEC.
Conclusions Alterations to claudin proteins may reflect changes seen to intestinal permeability and inflammation in the context of
NEC. Further research is necessary to understand the relevance of claudin proteins in the pathophysiology of NEC and their use
as a biomarker.
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Introduction
Necrotizing enterocolitis (NEC) is a severe inflammatory
bowel disease affecting preterm neonates born with birth
weights less than 1500 g, at an incidence of 7–10% and up
to 30% mortality [1]. Risk factors for NEC consistently in-
clude low birth weight and prematurity, as well as formula
feeding and intestinal dysbiosis [2]. Despite being described
nearly 40 years ago, a clear understanding of the pathophysi-
ology of NEC is lacking [3]. A reliable and specific biomarker
for the prediction or early diagnosis of NEC is an area of
current interest, with a recent review highlighting the impor-
tance of researching “gut-associated specific biomarkers” for
clinical application [4].
The intestinal epithelial surface is the primary barrier
protecting the body against invasion of pathogens introduced
by the gastrointestinal tract, and is formed by an epithelial
layer stabilized by tight junctions [5]. Tight junctions are
cell-cell adhesion complexes found on the apical portion of
intestinal epithelial cells [6, 7]. Tight junctions are composed
of 50 specific proteins, the major two being occludin and
claudin proteins which are anchored to the actin cytoskeleton
by scaffolding proteins known as zona occludens [8].
This review of literature focuses on the role of claudin
proteins in relation to intestinal stability in the context of
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NEC. The use of claudin proteins as potential biomarkers was
considered based on evidence of correlations between claudin
protein expression changes seen in human preterm neonates
and animal models with clinical features consistent with NEC.
Methods
Articles were searched using the following databases:
Pubmed, Web of Science, and ScienceDirect. Guidelines
looked up on included PRISMA, MOOSE, and Cochrane
Handbook of Systematic Reviews of Interventions.
Search terms used were “claudin” + “necrotizing enteroco-
litis.” A search filter was applied for studies performed be-
tween 2010 and 2019. All studies in the review were selected
using these databases; none was hand-selected. Studies relat-
ing to the claudin tight junction and necrotizing enterocolitis
were selected. The most recent search was performed on
December 06, 2019.
This search yielded 110 results. The most recent work done
on tight junction proteins in relation to NEC has been done on
mammalian animal models. Therefore, it was decided to con-
centrate on studies performed on recognized animal models
and humans rather than cell-based experimental studies.
Inclusion criteria were as follows: Studies performed be-
tween 2010 and 2019 to highlight recent work in this area,
studies performed on above terminologies along with overlap-
ping terminologies, and studies focusing on human NEC or
mammalian models of NEC.
Exclusion criteria were as follows: Studies performed in
2009 or prior, studies performed in 2020, studies that focused
on research methodology, and studies performed using cell/
molecular models or non-mammalian species. Excluded stud-
ies were determined based upon review of article abstracts or
summaries.
Following the application of these criteria, 27 papers
were selected for review. The relationship of tight junction
changes, specifically claudin proteins, seen in both human
and animal models with similar characteristics to human
NEC was focused on during this review, and a summary
of the results is provided in Table 1. The results are cate-
gorized based on appreciated associations with the devel-
opment of NEC in humans: (1) intestinal prematurity and
permeability, (2) gut microbiota and probiotic supplemen-
tation, (3) intestinal inflammation and injury, (4) breast
milk, and (5) systemic associations seen in extraintestinal
tissues. This categorization is to allow for a clearer break-
down of how claudin changes may be involved in the path-
ogenesis of NEC, and how changes seen with intestinal and
extraintestinal systems may be correlated. This could allow
the development of a noninvasive biomarker of intestinal
disease utilizing claudin changes.
Results
Intestinal prematurity and permeability
Understanding how prematurity contributes to the develop-
ment of NEC and how these changes are reflected through
tight junctions may enhance our understanding of the patho-
genesis of this disease. Increased gut permeability is a signif-
icant feature of NEC, which contributes to the translocation of
pathogenic bacteria and intestinal injury. Correlations be-
tween claudin protein expression changes and intestinal per-
meability have been observed. Elevated claudin-2 and re-
duced claudin-1, -3, and -4 expression was appreciated in a
rat model of NEC, with increased barrier permeability seen in
accordance with these claudin expression changes [9]. In a
mouse model of NEC, an elevation in claudin-2 expression
and internalization of claudin-4 was shown to precede intesti-
nal permeability in a time-dependent manner [10]. Elevated
claudin-2 expression was shown in the crypts of colonic epi-
thelium and small intestines from surgical samples of human
neonatal NEC patients [10]. Reduced claudin-4 gene expres-
sion has been appreciated in human preterm neonates with
NEC [11]. This change seen in claudin expression in addition
to other tight junction genes (ZO-1, occludin, cingulin) sug-
gests that alterations to tight junction proteins are relevant in
NEC [11]. Nitric oxide synthase (NOS2) was found to be
highly expressed in preterm infants with NEC, and may have
a role in mediating epithelial injury [12]. EGF has been shown
to have a protective effect on human neonatal intestinal ex-
plants leading to improved tight junction integrity, while ad-
ministration of indomethacin (INDO) was associated with
barrier disruption and was associated with reduced claudin-1
and -7 expression, and overexpression of claudin-2 [12].
Gut microbiota and probiotic supplementation
The presence of commensal bacterial species or administra-
tion of probiotics may have an impact on the expression of
claudin proteins and the stability of the intestinal barrier.
Administration of the probiotic Bifidobacterium infantis was
shown to attenuate tight junction expression changes by inter-
nalizing claudin-4 and subsequently decreasing incidence of
NEC in a mouse model [10]. A study revealed that the admin-
istration of Bifidobacterium led to reduced claudin-3 expres-
sion and reduced intestinal inflammation in a rat model [13].
The expression of claudin-3 in response to Lactobacillus
has been focused on in mouse models, with elevated expres-
sion of claudin-3 being associated with the colonization of
commensal bacteria and gut maturation [14, 15]. Claudin-3
expression appears to be upregulated during the first 2–3
weeks of life while the intestine matures, with both live- and
heat-killed Lactobacillus rhamnosus GG (LGG), potentially
accelerating this process of maturation through tight junction
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Table 1 Summary of claudin isoform changes seen in animal and human models of NEC.
Study Model Claudin findings
Prematurity
Bein et al. (2018) Human ↓ Claudin-4 gene expression appreciated in human preterm neonates with NEC.
Ferretti et al. (2017) Human ↓ Claudin-1, ↑ claudin-2, and ↓ claudin-7 seen in human preterm neonatal interstitial explants treated with
indomethacin (INDO) was associated with barrier disruption, mediated through the highly expressed nitric
oxide synthase (NOS2) enzyme, whereas EGF was shown to have a protective effect through a similar
pathway.




MouseHuman ↑ Claudin-2 and internalization of claudin-4 shown to precede intestinal permeability in a time-dependent
manner in a mouse model, prior to evidence of histological injury. Human tissue samples showed




Mouse Claudin-4 expression levels were preserved after administration of B. infantis, which correlated with reduced
incidence of NEC in the mouse model and a preservation of intestinal permeability.
Ling et al. (2016) Rat ↑ Claudin-3 expression normalized after administration of Bifidobacterium and was associated with decreased
incidence and severity of NEC by reducing gut permeability in a rat model.
Patel et al. (2012) Mouse ↑ Claudin-3 expression associated with colonization of commensal bacterial and enteral administration of
Lactobacillus in the mousemodel, suggesting role for claudin-3 in the stability of the intestinal barrier through
maturation of tight junctions.
Jakaitis and Denning
(2017)
Mouse ↑ Claudin-3 expression in the first 2–3 weeks of life in a mouse model which correlated with intestinal maturity




Siggers et al. (2011) Pig ↑ Claudin-1 in response to enteral feeding of formula following 2 days of TPN, in contrast to colostrum feeding
which reflected no change from the baseline.
Ravisankar et al.
(2018)
Mouse ↑ Claudin-2, ↓ claudin-3, ↓ claudin-4, and ↓ claudin-7 expression in mouse model of NEC induced by formula
feeding, cold stress, and hypoxia and is associated with elevated apoptosis (PARP), inflammatory markers
(NF-κB and TGF-β), and intestinal permeability.
Roy et al. (2018) Pig ↓ Claudin-2 expression associated with elevated intestinal permeability and inflammation in a newborn pig
model fed fermented formula.
Nutrition
Xu et al. (2018) Pig ↑ Claudin-1 expression with supplementation of medium-chain TAG (MCT) in diets of piglets compared to
maise oil diet. Suggests a protective role for MCT in improving intestinal barrier digestive function following
LPS challenge, mediated through changes in claudin proteins
Xiao, Cao, et al.
(2016)
Pig ↑ Claudin-1 expression in the jejunum following supplementation with dietary anemonin with alleviation of
LPS-induced intestinal injury and inflammation
Zhu et al. (2018) Pig ↑ Claudin-1 expression in intestines when supplemented with flaxseed oil, associated with intact epithelial
barrier and reduced inflammation in pig model exposed to LPS.
Xiao et al. (2018) Mouse ↑Claudin-1 expression and lower inflammatory markers in response to vitamin A treatment in the mouse model.
Low vitamin A levels are associated with human NEC.
Xiao, Jiao, et al.
(2016)
Pig Prevention of LPS-induced claudin-1 downregulation following administration of whey protein concentrate
(WPC) and inflammation in jejunal mucosa. Suggests that WPC may help attenuate LPS-induced intestinal
damage and stabilize the mucosal barrier.
Li et al. (2013) Pig ↑ Claudin-4 expression in a pig model fed conventional formula, correlated with intestinal permeability and
increases in response to epithelial damage in the preterm pig model. Normalization of claudin-4 expression
with supplementation of whey protein concentrate
Enzymes and peptides
Seo et al. (2019) Mouse ↓ Claudin-3 gene expression in NEC mouse model, with administration of vasoactive intestinal peptide (VIP)
leading to ↑ claudin-3 gene expression in the crypts of NEC animals.
Rentea et al. (2012) Rat ↓ Claudin-1 and ↑ claudin-3 expression correlated with decreased intestinal permeability and severity of NEC
with supplementation of intestinal alkaline phosphatase in the rat model
Ares et al. (2019) Rat Rho kinase inhibition may have a protective role by normalizing claudin-2 expression in a rat model.
Ischemia
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modification [14]. Mice with deficient colonization of com-
mensal bacteria had impaired barrier function and reduced
claudin-3 expression, which was remedied following admin-
istration of both live- and heat-killed LGG with a lower mor-
tality rate seen in the latter [15].
Intestinal inflammation and injury
Role of formula feeding on intestinal inflammation
Formula feeding may be associated with changes to claudin
protein expression and correlate with intestinal damage. In
response to enteral feeding of formula following 2 days of
TPN, elevated claudin-1 transcription was appreciated in a
pig model, in contrast to colostrum feeding which reflected
no change from baseline [16]. In a mouse model fed formula,
elevated claudin-2 and reduced claudin-3, -4, and -7 expres-
sion was associated with elevated apoptosis mediated by poly
ADP-ribose polymerase (PARP), inflammatory markers
(NF-κB and TGF-β) and intestinal permeability [17].
Elevated intestinal permeability and inflammationwere appre-
ciated in a newborn pig model induced by feeding fermented
formula, which correlated with reduced claudin-2 expression
[18].
Role of nutritional supplementation on intestinal
inflammation
The influence of enteral supplementation of nutritional sub-
stances has been explored, with a major focus on changes seen
to claudin-1 levels. In pig models, supplementation with
medium-chain tri-acyl glycerides (MCT) and dietary
anemonin was both shown to improve intestinal inflammation
following lipopolysaccharide (LPS)-induced injury and corre-
lated with elevated claudin-1 expression [19, 20]. Flaxseed oil
supplementation led to elevated claudin-1 expression in the
intestines of a pig model exposed to LPS and correlated with
an intact epithelial barrier with reduced inflammation [21].
Low vitamin A (VA) levels have been associated with human
NEC. Elevated claudin-1 expression and reduced inflamma-
tory markers have been appreciated in a mouse model of NEC
supplemented with VA [22]. Whey protein concentrate
(WPC) was also shown to prevent an LPS-induced decrease
in claudin-1 expression and inflammation in the jejunal mu-
cosa of a pig model, suggesting a role for WPC in attenuating
LPS-induced intestinal damage and stabilization of the muco-
sal barrier [23]. Additionally, a preterm pig model fed con-
ventional formula correlated with elevated claudin-4 expres-
sion, intestinal permeability, and increased epithelial damage,
which normalized after supplementation with whey protein
concentrate [24].
Role of intestinal enzymes and peptide supplementation
on intestinal inflammation
The presence of certain enzymes and peptide products may
have a role in adjusting the intestinal barrier and influencing
the progression of NEC. Reduced claudin-3 gene expression
was appreciated in a NEC mouse model, with the administra-
tion of VIP subsequently leading to increased claudin-3 gene
expression, reduced inflammation, and reduced tight junction
disruption in the intestinal epithelium [25]. Reduced claudin-1
Table 1 (continued)
Study Model Claudin findings
Jensen et al. (2017) Mouse Preservation of claudin-1 levels and intestinal stability in a mouse model given human adipose–derived stromal
stem cell (hASC) therapy, likely due to improved mesenteric perfusion and intestinal mucosal integrity.
Hogberg et al.
(2013)





Mouse ↑ Claudin-2, ↑ claudin-3, and ↑ claudin-4 ileal expression associated with increased survival and lower intestinal
injury in NEC+HA35- and HA35-treatedmouse models compared to untreatedNECmouse model. The effect
of hyaluronan (HA), a human milk glycosaminoglycan, was shown to reduce intestinal permeability, bacterial
translocation, and pro-inflammatory cytokine release.
Shen et al. (2019) Rat ↑ Claudin-3 expression in the ileum of rat model. Supplementation with lactadherin associated with reduced
claudin-3, histological damage, intestinal permeability, and incidence of NEC
Systemic associations
Garg et al. (2015) Mouse ↑claudin-1, ↑claudin-2, ↑claudin-3 and ↑claudin-4, ↑claudin-7, and ↑claudin-8 has been appreciated in tight




Human ↓ Claudin-2 expression in intestinal epithelium and ↑ claudin-2 expression in urine found to correlate with
severity of NEC independent of other conditions in human neonates.
Thuijls et al. (2010) Human ↑ Claudin-3 in urine of human neonates with suspected NEC that later on developed NEC.
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and elevated claudin-3 expression levels correlated with re-
duced intestinal permeability and severity of NEC in a rat
model after supplementation with intestinal alkaline phospha-
tase (IAP) [26]. Inhibition of Rho kinase (ROCK), which af-
fects cell permeability through the regulation of tight junc-
tions, was shown to have a protective role by normalizing
claudin-2 expression in a rat model [9].
Ischemia and necrosis
The progression of ischemia and necrosis within the intestines
of NEC patients may be associated with changes to claudin
proteins. Treatment with human adipose–derived stromal
stem cell (hASC) therapy in a mouse model resulted in re-
duced mortality possibly due to improved mucosal integrity
and perfusion, which correlated with elevated claudin-1 [27].
Hypoxic-reoxygenation therapy mimicked early pathogenesis
of NEC in a rat model, and was associated with the downreg-
ulation of claudin-1, -14, and -15 and upregulation of claudin-
8 [28].
Breast milk
Components of breast milk may have a role in physiologically
stabilizing the intestinal barrier through changes in the expres-
sion of claudin proteins. Elevated claudin-2, -3, and -4 expres-
sion in the ileum of NEC mouse models treated with
hyaluronan (HA)-35 was associated with increased survival
and lower intestinal injury [29]. Supplementation with
lactadherin, an immune-related glycoprotein in human milk,
leads to reduced claudin-3 expression, intestinal permeability,
and incidence of NEC in a rat model [30].
Systemic associations
Changes seen in claudin proteins have been studied in extra-
intestinal tissues and correlated with the clinical progression
of NEC in humans and animal models. Elevated claudin-1, -2,
-3, -4, and -8 has been appreciated in tight junctions of site-
specific regions of the nephron in a mouse model induced by
formula feeding, hypoxia, and cold stress [31]. Reduced
claudin-2 expression in the intestinal epithelium and an eleva-
tion in claudin-2 protein in the urine were shown to correlate
with the severity of NEC in a small study of human neonates,
and was shown to be independent of other conditions includ-
ing sepsis, medication use, or ventilation [32]. An elevated
level of urinary claudin-3, urinary intestinal fatty-acid binding
protein (I-FABP), and fecal calprotectin has been appreciated
in samples from human neonates with suspected NEC who
later went on to develop the disease, with urinary I-FABP
being useful in predicting the severity of NEC [33].
Discussion
Understanding the role that claudins may have on the stability
and permeability of the premature gut barrier, and how expres-
sion of claudin proteins change in response to a variety of risk
factors associated with the development of NEC is the focus
of this literature review. By having a clearer idea of claudin
proteins in the progression of NEC, this knowledge may be
applied to the development of a novel biomarker for this dis-
ease in order to predict the severity of NEC, or as a therapeutic
target.
Intestinal permeability is a natural phenomenon seen in
premature infants to improve intestinal absorption of nutrients
from breast milk, including immunoglobulins. Alterations to
claudin-1, -2, -3, -4, and -7 have been shown in human and
animal models of NEC, and appear to have a central role in
contributing to intestinal stability and permeability of the in-
testinal epithelium [9–12]. Claudin-2 expression changes have
been shown to precede changes in intestinal permeability in a
mouse model, with elevated claduin-2 expression demonstrat-
ed in surgical samples from human NEC [10]. This temporal
pattern may encourage future studies to focus on changes in
claudin proteins in advance of the development of NEC and
may be useful as a biomarker for intestinal injury in infants at
risk of developing NEC.
Interactions between the gut microbiota and tight junction
stability reflect the dynamic nature of the preterm intestinal
barrier. Bacterial dysbiosis has been appreciated in the patho-
genesis of NEC, which refers to the imbalance of commensal
bacterial and a low diversity of bacteria, leading to the prolif-
eration of pathogenic species contributing to intestinal inflam-
mation [34]. A diverse gut microbiota with the presence of
commensal species may have a role in reducing intestinal
inflammation and improving intestinal stability through mat-
uration of claudin proteins, particularly claudin-3 and claudin-
4 [10, 13–15]. Further research into how commensal species
stabilize the intestine through tight junctions may be useful
when considering probiotics as a potential therapy in the pre-
vention or treatment of NEC by promoting neonatal intestinal
maturity. Additionally, it appears claudins may have a role in
stabilizing the intestinal barrier during the first few weeks of
life, which may be a useful characteristic while searching for a
biomarker that detects the early progression of NEC.
Intestinal inflammation and permeability lead to the trans-
location of bacteria and a detrimental systemic inflammatory
response in premature neonates with NEC. Formula feeding
may contribute to intestinal inflammation through modifica-
tion of the epithelial tight junction barrier. Based on the
reviewed studies, formula feeding was shown to result in
changes in the expression of claudin-1, -2, -3, -4, and -7
[16–18]. Although there appears to be species-specific differ-
ences in whether certain claudins are up- or downregulated,
formula feeding was associated with changes to claudin
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expression, increased inflammation, and intestinal permeabil-
i ty in mouse and pig models o f NEC [16–18] .
Supplementation with nutritional substrates including MCT,
dietary anemonin, flaxseed oil, and WPC was shown to im-
prove intestinal inflammation and intestinal stability in pig
models of NEC, with changes primarily seen with claudin-1
expression [19–21, 23]. Additionally, vitamin A which has
been observed as being deficient in NEC patients was shown
to improve intestinal inflammation in a mouse model, which
correlated with elevated claudin-1 [22]. Further research fo-
cusing on how the supplementation of certain factors influ-
ences the intestinal barrier to improve stability and reduce
inflammation may be a potential therapeutic intervention,
and may continue to support a role for claudin proteins in
mediating these protective effects.
The supplementation of enzymes, including VIP and IAP,
and the inhibition of ROCK were shown to have protective
effects on the intestinal epithelium by reducing intestinal in-
flammation and improving tight junction stability through
claudin expression changes [9, 25, 26]. Based on these stud-
ies, various supplements may have a therapeutic role in
adjusting the progression of NEC by modifying tight junction
proteins to reduce intestinal permeability and inflammation.
Further research on the mechanism by which supplements
improve the intestinal barrier through the regulation of
claudins supports their use as a marker of intestinal integrity.
Alterations to musical integrity and perfusion may have a
role in the progression of NEC. Changes seen in claudin-1, -8,
-14, and -15 in response to a hypoxic environment indicate
that claudins may be a useful marker for detecting the progres-
sion of ischemic damage in NEC patients [27, 28]. Additional
studies will be required to understand the role hypoxic damage
in the context of NEC, and how claudins may be a useful
marker of intestinal damage due to hypoxic injury.
Breastfeeding has appreciated benefits in the prevention of
NEC; however, the exact mechanism has yet to be clarified.
The role of tight junctions in mediating the beneficial effects
of breastfeeding on intestinal stability may be significant.
Claudin-2, -3, and -4 appear to be influenced by components
of breast milk including hyaluronan and lactacdherin to alter
intestinal stability and injury in both mouse and rat models
[29, 30]. The direct effect of breast milk on intestinal perme-
ability and protection from the development of NEC may be
an area for future studies to explore whether the protective
effects of breast milk can be attributed to the regulation of
tight junction proteins.
This review highlights the involvement of the kidneys in
the multisystem pathophysiology of NEC. Elevated claudin-1,
-2, -3, -4, and -8 has been appreciated within tight junctions of
the nephron in a mouse model in the context of various risk
factors for NEC including formula feeding, hypoxia, and hy-
pothermia [31]. Recent studies using urinary samples to mea-
sure claudin proteins in the context of human NEC have
promising results. Reduced intestinal claudin-2 and elevated
urinary claudin-2 levels were shown to correlate with the se-
verity of NEC in human neonates [32]. Elevated urinary
claudin-3, urinary I-FABP, and fecal calprotectin have also
been appreciated in human samples that developed NEC
[33]. These studies demonstrate a possible link between sys-
temic and intestinal claudin changes, which may be useful in
larger studies focusing on noninvasive measurements of intes-
tinal damage which correlates to the clinical progression of
NEC. Based on the papers reviewed in this study, changes
seen in claudin proteins appear across relevant risk factors
for NEC and potentially in a time-dependent manner along-
side intestinal permeability, which supports claudin proteins
as a promising avenue for future studies towards a biomarker
for NEC.
Conclusion
An appropriate noninvasive clinical biomarker to detect NEC
is an area of interest, with claudin proteins being a candidate
for future studies. Studies with animal models and human
NEC demonstrate a possible correlation between claudin pro-
tein expression changes and factors that influence the intesti-
nal barrier, including various understood risk factors for NEC
such as intestinal permeability, altered gut microbiota, intesti-
nal inflammation, and breastfeeding. Although these reviewed
studies focused primarily on animal models and small studies
in human preterm neonates, recent studies support that claudin
protein expression changes may be measurable in a noninva-
sive manner, with correlations between intestinal claudin and
urinary claudin changes being a possible biomarker to detect
NEC in at risk neonates.
Future studies are required to understand how claudin iso-
form expression is influenced in the progression of NEC and
how this knowledge can be translated to the use of claudins as
a biomarker. Future directions include exploring the relation-
ship between disrupted tight junctions and how this directly
relates with the inflammation and severity of NEC.
Understanding how changes seen in the expression of claudin
isoforms changes under a variety of physiological circum-
stances will contribute towards their use as a biomarker may
provide an avenue for the prevention or management of NEC
by modulating the immature gut barrier through tight junction
modification.
Claudins and other tight junction proteins appear to have a
measurable role in the pathogenesis of NEC as a marker of
intestinal permeability. Changes in claudin proteins in tissue
samples may be a useful clinical marker to detect NEC in early
stages to ensure adequate intervention or prevention of NEC
in premature neonates at risk for the development of this
disease.
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